Vitalah® is committed to providing the highest quality dietary supplements, and part of that commitment is ensuring that each formulation includes the safest, most efficacious ingredients on the market. That's why Vitalah recently made three upgrades to its Adult Oxylent® formula: switching the source of folate from folic acid to 5-MTHF (5-methyltetrahydrofolate); changing the source of iodine from potassium iodide to kelp; and adding in sources of vitamins A and E.
SAN ANTONIO (May 17, 2016) – Mission Pharmacal Company today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for over-the-counter liquid Potassium Iodide Oral Solution USP. The solution is a ready to use thyroid blocking medication that can be used by all ages in the event of a nuclear emergency. Although potassium iodide tablets are available, the FDA recommends a liquid oral solution for infants and small children because it allows for accurate and precise dosing.
Mission Pharmacal`s Generic Potassium Iodide approved in US to treat Hyperthyroidism